| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |